Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ACTAVIS INC
03/15 ACTAVIS : to sponsor 2015 LifeCycle Challenge
03/15 TREVENA : Reports on Phase 2b BLAST-AHF Trial of TRV027
03/13 ACTAVIS : Entry into a Material Definitive Agreement, Creation of a Direct Finan..
03/13 ALLERGAN : Actavis and Allergan Shareholders OK Proposals Related to Planned Acq..
03/13 ALLERGAN : Actavis and Allergan Shareholders OK Proposals for Actavis' Acquisiti..
03/13 ALLERGAN : Actavis and Allergan Shareholders OK Proposals Related to Actavis' Pl..
03/13 ACTAVIS : Receives FDA Approval of SAPHRIS® for Pediatric Patients (age 10-17) f..
03/12 ACTAVIS : Confirms Appeals Court Grants Injunction Pending Appeal Related to Gen..
03/12 ACTAVIS : Entry into a Material Definitive Agreement, Other Events, Financial St..
03/12 ACTAVIS : Announces Closing of Public Offering of Senior Notes in Connection wit..
03/12 TREVENA : Updates on Phase 2b BLAST-AHF Trial of TRV027
03/11 Federal Appeals Court Affirms Dismissal of Class Action Lawsuit
03/11DJEndo Makes Takeover Offer for Salix Pharmaceuticals--6th Update
03/11DJEndo Makes Takeover Offer for Salix Pharmaceuticals--5th Update
03/11 ACTAVIS : Announces Proposed Public Offering of Senior Notes in Connection with ..
03/11DJEndo Makes Takeover Offer for Salix Pharmaceuticals--4th Update
03/11DJEndo Makes Takeover Offer for Salix Pharmaceuticals--3rd Update
03/11DJEndo Makes Takeover Offer for Salix Pharmaceuticals--2nd Update
03/11DJEndo Makes Takeover Offer for Salix Pharmaceuticals--Update
03/11 ALLERGAN : Actavis Announces Closing of Public Offerings of Ordinary Shares and ..
03/10 ACTAVIS : Submission of Matters to a Vote of Security Holders, Other Events, Fin..
03/10DJACTAVIS : Allergan Shareholders Approve $66 Billion Deal
03/10 ACTAVIS : and Allergan Shareholders Approve Proposals Related to Actavis’ ..
03/09 ACTAVIS : Launches Generic Version of Temovate® (clobetasol cream 0.05%)
03/09DJPershing Square Takes 5% Stake in Valeant -- Update
03/09DJPershing Square Takes 5% Stake in Valeant
03/06 ACTAVIS : Entry into a Material Definitive Agreement, Other Events, Financial St..
03/06 ACTAVIS : Other Events (form 8-K)
03/05DJForeign Takeovers See U.S. Losing Tax Revenue
03/04 ACTAVIS : Confirms District Court Ruling In Atelvia® Patent Litigation
03/04DJU.S. Government Bonds Pause After 2-Day Selloff
03/04 ACTAVIS : Receives U.S. FDA Approval for AVYCAZ™ CEFTAZIDIME-AVIBACTAM
03/04 ACTAVIS : and Medicines360 Announce FDA Approval of LILETTA™ levonorgestre..
03/04 ALLERGAN : Actavis Announces Pricing of Public Offerings of Ordinary Shares and ..
03/04DJU.S. Government Bonds Little Changed on Mixed Data
03/04 ACTAVIS : Other Events, Financial Statements and Exhibits (form 8-K)
03/04 ACTAVIS : AstraZeneca completes acquisition of rights to Actavis' branded respir..
03/03 ACTAVIS : Announces Pricing of Public Offering of Senior Notes in Connection wit..
03/03DJBOND REPORT : Flurry Of Debt Offerings Drives Treasury Yields Higher
03/03DJU.S. Government Bonds Fall, Stung by Corporate Debt Issuance
03/03DJActavis Prices $21 Billion Bond--Update
03/03 U.S. stocks recede from record highs, dollar slips
03/03DJBOND REPORT : Treasury Yields Rise As Investors Buy Corporate Debt
03/03DJActavis Launches $21 Billion Bond Sale
03/03DJU.S. Government Bonds Fall, as Corporate Sales Compete
03/03DJActavis Lowers Yields On Megabond Sale
03/03 ASTRAZENECA : Acquisition of Rights to Actavis' Portfolio
03/03DJASTRAZENECA : Completes Acquisition of Rights to Actavis' Portfolio
03/03DJAstraZeneca PLC Acquisition of Rights to Actavis' Portfolio
03/03 ACTAVIS : Adamas Reports Fiscal 2014 Financial Results
03/02 ACTAVIS : and Medicines360 get FDA approval for pregnancy prevention drug Lilett..
03/02 ACTAVIS : Entry into a Material Definitive Agreement, Material Modification to R..
03/02DJActavis to Wrap Up Mega-Bond Sale on Tuesday
03/02 ACTAVIS : Announces Closing of Public Offerings of Ordinary Shares and Mandatory..
03/02DJU.S. Government Bonds Sell Off Again After Brutal February
03/02DJU.S. Treasurys Off to Rough Start in March
03/02DJActavis to Tap Bond Market This Week With Mega Deal
03/02 ACTAVIS : Receives Approval from the European Commission for XYDALBA(TM) (dalbav..
03/02 ACTAVIS : Other Events, Financial Statements and Exhibits (form 8-K)
03/02 ACTAVIS : Announces Proposed Public Offering of Senior Notes in Connection with ..
03/02DJMARKET SNAPSHOT : U.S. Stocks: Futures Edge Higher Ahead Of Data Deluge
03/02DJMARKET SNAPSHOT : U.S. Stocks: Futures Climb Ahead Of Data Deluge
03/02 ACTAVIS : Readies Big Bond Deal
03/01DJActavis Readies Big Bond Deal
02/27 ACTAVIS : Novan Expands Leadership Team with Vice President of Regulatory Affair..
02/27 AstraZeneca to carve out antibiotic R&D into separate firm
02/26 ACTAVIS : Launches Generic Pulmicort RESPULES®
02/26 ACTAVIS : Announces Intention to Adopt "Allergan" Corporate Name
02/25 ALLERGAN : Actavis Announces Proposed Public Offerings of Ordinary Shares and Ma..
02/25 ACTAVIS : FDA approves new antibiotic combo from Actavis
02/25 ACTAVIS : Receives U.S. FDA Approval for AVYCAZ(TM) (CEFTAZIDIME-AVIBACTAM)
02/25 ACTAVIS : Non-GAAP Net Revenue Increases 44% to $4 Billion in Fourth Quarter 201..
02/25 ACTAVIS : Other Events, Financial Statements and Exhibits (form 8-K)
02/25 ACTAVIS : Announces Pricing of Public Offerings of Ordinary Shares and Mandatory..
02/24 ACTAVIS : Confirms Generic Uceris® Patent Challenge
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF